Product Code: ETC051370 | Publication Date: Aug 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Vietnam gastrointestinal drugs market has experienced growth as a result of the country`s evolving healthcare system and rising cases of gastrointestinal disorders. Gastrointestinal drugs, including antacids and antiemetics, are essential in managing digestive health issues. The pandemic placed significant pressure on healthcare resources, affecting the availability of medical treatments. Nevertheless, as the healthcare system strengthens, the demand for gastrointestinal drugs is projected to increase to cater to the healthcare needs of the population.
The Vietnam gastrointestinal drugs market has been driven by several key factors. Firstly, the increasing prevalence of gastrointestinal disorders, including gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and peptic ulcers, has been a major driver for the market. Factors such as changing dietary habits, stressful lifestyles, and an aging population have contributed to the rise in gastrointestinal issues. Secondly, the expanding healthcare infrastructure and improved access to medical facilities in Vietnam have led to higher diagnosis and treatment rates for gastrointestinal disorders. As healthcare services become more accessible, the demand for gastrointestinal drugs has increased. Thirdly, the growing awareness of gastrointestinal health and the availability of a wide range of drugs to manage these conditions have further boosted the demand for gastrointestinal drugs. However, the COVID-19 pandemic placed significant pressure on healthcare resources, affecting the availability of medical treatments. Despite this, as the healthcare system strengthens and adapts to the changing healthcare landscape, the demand for gastrointestinal drugs is projected to increase to cater to the healthcare needs of the population.
The Vietnam gastrointestinal drugs market faces challenges related to the affordability and accessibility of medications. As the prevalence of gastrointestinal disorders increases, ensuring access to essential medications at an affordable cost becomes crucial. Secondly, the widespread use of over-the-counter (OTC) drugs for gastrointestinal issues can impact the growth of prescription medications in this market. Effective regulation and education on the appropriate use of medications are necessary to strike a balance between OTC and prescription drugs. Thirdly, counterfeit and substandard drugs pose a risk to patient safety and can undermine trust in the pharmaceutical industry. Strengthening regulatory measures to combat the production and distribution of counterfeit drugs is essential.
The COVID-19 pandemic impacted the Vietnam gastrointestinal drugs market as the healthcare system focused on responding to the pandemic and managing COVID-19 cases. Non-urgent medical appointments and elective procedures, including those related to gastrointestinal disorders, faced delays or cancellations. The disruption in medical services and healthcare facilities impacted patient access to gastrointestinal drugs and treatments. The healthcare resources diverted to manage the pandemic led to challenges in providing continuous care for patients with gastrointestinal conditions. Additionally, the pandemic led to disruptions in the pharmaceutical supply chain, affecting the availability and distribution of medications, including gastrointestinal drugs. Import-dependent pharmaceutical companies faced challenges in sourcing raw materials and finished products. As the healthcare system adapts and healthcare services resume, the demand for gastrointestinal drugs is expected to gradually recover in the post-pandemic period, driven by the increasing prevalence of gastrointestinal disorders and the growing healthcare needs of the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Gastrointestinal Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Gastrointestinal Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Gastrointestinal Drugs Market - Industry Life Cycle |
3.4 Vietnam Gastrointestinal Drugs Market - Porter's Five Forces |
3.5 Vietnam Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.6 Vietnam Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Vietnam Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Vietnam Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2021 & 2031F |
4 Vietnam Gastrointestinal Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Gastrointestinal Drugs Market Trends |
6 Vietnam Gastrointestinal Drugs Market, By Types |
6.1 Vietnam Gastrointestinal Drugs Market, By Drug Category |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Drug Category, 2021-2031F |
6.1.3 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Antiemetic, 2021-2031F |
6.1.4 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Acid Neutralizers, 2021-2031F |
6.1.5 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Anti-inflammatory, 2021-2031F |
6.1.6 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Laxatives & Antidiarrheal, 2021-2031F |
6.1.7 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Vietnam Gastrointestinal Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Rectal, 2021-2031F |
6.3 Vietnam Gastrointestinal Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.3 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
6.3.4 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4 Vietnam Gastrointestinal Drugs Market, By Disease Types |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Inflammatory Bowel Diseases, 2021-2031F |
6.4.3 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Gastroesophageal Reflux Diseases, 2021-2031F |
6.4.4 Vietnam Gastrointestinal Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Vietnam Gastrointestinal Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Gastrointestinal Drugs Market Export to Major Countries |
7.2 Vietnam Gastrointestinal Drugs Market Imports from Major Countries |
8 Vietnam Gastrointestinal Drugs Market Key Performance Indicators |
9 Vietnam Gastrointestinal Drugs Market - Opportunity Assessment |
9.1 Vietnam Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
9.2 Vietnam Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Vietnam Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Vietnam Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2021 & 2031F |
10 Vietnam Gastrointestinal Drugs Market - Competitive Landscape |
10.1 Vietnam Gastrointestinal Drugs Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |